Found: 30
Select item for more details and to access through your institution.
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR).
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-019-0977-z
- By:
- Publication type:
- Article
Rationale and design of study of dapagliflozin versus sitagliptin treatment efficacy on prevention of cardiovascular risk factors in type 2 diabetes patients: the DIVERSITY-CVR study.
- Published in:
- Cardiovascular Diabetology, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12933-018-0730-z
- By:
- Publication type:
- Article
Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis.
- Published in:
- Nature Medicine, 2014, v. 20, n. 7, p. 759, doi. 10.1038/nm.3579
- By:
- Publication type:
- Article
Whole hepatic lipid volume quantification and color mapping by multi‐slice and multi‐point magnetic resonance imaging.
- Published in:
- Hepatology Research, 2019, v. 49, n. 12, p. 1374, doi. 10.1111/hepr.13408
- By:
- Publication type:
- Article
Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub‐analysis of the DIVERSITY‐CVR study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2131, doi. 10.1111/dom.15089
- By:
- Publication type:
- Article
Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue‐specific insulin sensitivity in patients with early‐stage type 2 diabetes with non‐alcoholic fatty liver disease: A prospective randomized study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1576, doi. 10.1111/dom.15006
- By:
- Publication type:
- Article
Efficacy of intermittent empagliflozin supplementation on dietary self‐management and glycaemic control in patients with poorly controlled type 2 diabetes: A 24‐week randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 303, doi. 10.1111/dom.13524
- By:
- Publication type:
- Article
Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well‐controlled type 2 diabetes: A 24‐week randomized controlled trial.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 10, p. 1816, doi. 10.1111/jdi.13533
- By:
- Publication type:
- Article
Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium–glucose cotransporter 2 inhibitor: A randomized, open‐label, prospective study.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 4, p. 1022, doi. 10.1111/jdi.12994
- By:
- Publication type:
- Article
Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function.
- Published in:
- Journal of Diabetes Investigation, 2017, v. 8, n. 3, p. 330, doi. 10.1111/jdi.12587
- By:
- Publication type:
- Article
Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 8, p. 3326, doi. 10.1210/jc.2006-2384
- By:
- Publication type:
- Article
Effects of Diet and Exercise on Muscle and Liver Intracellular Lipid Contents and Insulin Sensitivity in Type 2 Diabetic Patients.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 6, p. 3191, doi. 10.1210/jc.2004-1959
- By:
- Publication type:
- Article
Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0564-0
- By:
- Publication type:
- Article
Acute suppurative thyroiditis in infected thyroid cyst in an adult patient under hemodialysis.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 5, p. 570, doi. 10.1002/ccr3.861
- By:
- Publication type:
- Article
A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01228-3
- By:
- Publication type:
- Article
Determinants of intramyocellular lipid accumulation after dietary fat loading in non-obese men.
- Published in:
- Journal of Diabetes Investigation, 2011, v. 2, n. 4, p. 310, doi. 10.1111/j.2040-1124.2010.00091.x
- By:
- Publication type:
- Article
Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Impact of Oxidative Stress and Peroxisome Proliferator-Activated Receptor γ Coactivator-1α in Hepatic Insulin Resistance.
- Published in:
- Diabetes, 2008, v. 57, n. 8, p. 2083, doi. 10.2337/db08-0144
- By:
- Publication type:
- Article
Rationale, Design for the ASSET Study: A Prospective Randomized Study Comparing Empagliflozin's Effect to Sitagliptin on Cardiac Fat Accumulation/Function in Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1509, doi. 10.1007/s13300-019-0640-4
- By:
- Publication type:
- Article
Up-Titration Strategy After DPP-4 Inhibitor-Based Oral Therapy for Type 2 Diabetes: A Randomized Controlled Trial Shifting to a Single-Dose GLP-1 Enhancer Versus Adding a Variable Basal Insulin Algorithm.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 5, p. 1959, doi. 10.1007/s13300-018-0486-1
- By:
- Publication type:
- Article
Glycemic Variability in Type 1 Diabetes Compared with Degludec and Glargine on the Morning Injection: An Open-label Randomized Controlled Trial.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 4, p. 783, doi. 10.1007/s13300-017-0269-0
- By:
- Publication type:
- Article
Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial.
- Published in:
- Endocrine Journal, 2016, v. 63, n. 12, p. 1087, doi. 10.1507/endocrj.ej16-0291
- By:
- Publication type:
- Article
A case of lean polycystic ovary syndrome with early stage of type 1 diabetes successfully treated with metformin.
- Published in:
- Endocrine Journal, 2016, v. 63, n. 2, p. 193, doi. 10.1507/endocrj.ej15-0548
- By:
- Publication type:
- Article
1865-P: SGLT2 Inhibition Compared with Iso-energetic/Low-Carbohydrate Diet Reprograms Systemic Substrate Oxidation in Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1865-P
- By:
- Publication type:
- Article
29-OR: Comparison of Empagliflozin and Sitagliptin on Ectopic Fat Accumulation and Tissue-Specific Insulin Sensitivity.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-29-OR
- By:
- Publication type:
- Article
1008-P: 3D Acoustic Radiation Force Impulse Virtual Imaging of Whole Human Abdominal Subcutaneous Tissue Imaging with "Insulin Ball".
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1008-P
- By:
- Publication type:
- Article
160-OR: Pretreatment Diabetes Has Lower Mortality Rate, Independent of Immune-Related Adverse Events, in Cancer Patients with Immune-Check Point Inhibitor.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-160-OR
- By:
- Publication type:
- Article
21-LB: The Study of Dapagliflozin vs. Sitagliptin Treatment Efficacy on Prevention of Cardiovascular Risk Factors in Type 2 Diabetes Patients: The DIVERSITYCVR Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-21-LB
- By:
- Publication type:
- Article
1893-P: Impact of Lean Hepatic Volume on Hepatic Insulin Resistance in Human NAFLD.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1893-P
- By:
- Publication type:
- Article
Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance.
- Published in:
- Diabetes, 2013, v. 62, n. 7, p. 2183, doi. 10.2337/db12-1311
- By:
- Publication type:
- Article